NDC 68428-974-11 Lithium Bromatum

Lithium Bromide

NDC Package Code 68428-974-11

The NDC Code 68428-974-11 is assigned to a package of 300 pellet in 1 bottle, glass of Lithium Bromatum, a human over the counter drug labeled by Washington Homeopathic Products. The product's dosage form is pellet and is administered via oral form.

Field Name Field Value
NDC Code 68428-974-11
Package Description 300 PELLET in 1 BOTTLE, GLASS
Proprietary Name Lithium Bromatum What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Lithium Bromide What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
11-Digit NDC Billing Format 68428097411 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Product Type Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Labeler Name Washington Homeopathic Products
Dosage Form Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route(s)
  • Oral - Administration to or by way of the mouth.
Active Ingredient(s)
  • LITHIUM BROMIDE 30 [hp_C]/1
Sample Package No Sample Package?
This field Indicates whether this package is a sample packaging or not.
Marketing Category UNAPPROVED HOMEOPATHIC - What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date 07-27-2011 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

NDC Code Structure

  • 68428 - Washington Homeopathic Products
    • 68428-974 - Lithium Bromatum
      • 68428-974-11 - 300 PELLET in 1 BOTTLE, GLASS

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for Lithium Bromatum with product NDC 68428-974.

NDC Package CodePackage Description
68428-974-0375 PELLET in 1 VIAL, GLASS
68428-974-05150 PELLET in 1 VIAL, GLASS
68428-974-061200 PELLET in 1 BOTTLE, GLASS
68428-974-12600 PELLET in 1 BOTTLE, GLASS

* Please review the disclaimer below.